162 related articles for article (PubMed ID: 23084576)
61. Bare-metal vs. drug-eluting stents in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Kiviniemi T; Puurunen M; Schlitt A; Rubboli A; Karjalainen P; Nammas W; Kirchhof P; Biancari F; Lip GY; Airaksinen KJ
Circ J; 2014; 78(11):2674-81. PubMed ID: 25298168
[TBL] [Abstract][Full Text] [Related]
62. Prognostic implications of procedural vs spontaneous myocardial infarction: results from the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry.
Bangalore S; Pencina MJ; Kleiman NS; Cohen DJ
Am Heart J; 2013 Dec; 166(6):1027-34. PubMed ID: 24268217
[TBL] [Abstract][Full Text] [Related]
63. Complete versus incomplete revascularization in patients with multivessel coronary artery disease treated with drug-eluting stents.
Chang M; Ahn JM; Kim N; Lee PH; Roh JH; Yoon SH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
Am Heart J; 2016 Sep; 179():157-65. PubMed ID: 27595691
[TBL] [Abstract][Full Text] [Related]
64. Effects of EPC capture stent and CD34+ mobilization in acute myocardial infarction.
Scacciatella P; D'Amico M; Pennone M; Conrotto F; Meliga E; Usmiani T; Meynet I; Gunetti M; Ferrero I; Rustichelli D; Fagioli F; Marra S
Minerva Cardioangiol; 2013 Apr; 61(2):211-9. PubMed ID: 23492604
[TBL] [Abstract][Full Text] [Related]
65. Outcomes of culprit versus multivessel PCI in patients with multivessel coronary artery disease presenting with ST-elevation myocardial infarction complicated by shock.
Cavender MA; Rajeswaran J; DiPaola L; Houghtaling P; Kiernan MS; Rassi AN; Menon V; Whitlow PW; Ellis SG; Shishehbor MH
J Invasive Cardiol; 2013 May; 25(5):218-24. PubMed ID: 23645045
[TBL] [Abstract][Full Text] [Related]
66. Adjunctive Bare-Metal Stenting Associated With Improved Outcomes in Patients With Multivessel Disease Treated With Drug-Eluting Stents.
Crooks N; Chan W; Ivanov J; Horlick EM; Ing D; Overgaard CB; Džavík V
Can J Cardiol; 2016 Oct; 32(10):1231-1238. PubMed ID: 26971235
[TBL] [Abstract][Full Text] [Related]
67. Favorable long-term survival in patients undergoing multivessel-PCI compared to predicted prognosis of CABG estimated by EuroSCORE: procedural and clinical determinants of long-term outcome.
Lehmann R; Fichtlscherer S; Schächinger V; Held L; Hobler C; Baier G; Zeiher AM; Spyridopoulos I
J Interv Cardiol; 2009 Dec; 22(6):511-9. PubMed ID: 19732282
[TBL] [Abstract][Full Text] [Related]
68. Effect of coronary thrombus aspiration during primary percutaneous coronary intervention on one-year survival (from the FAST-MI 2010 registry).
Puymirat E; Aissaoui N; Cottin Y; Vanzetto G; Carrié D; Isaaz K; Valy Y; Tchetche D; Schiele F; Steg PG; Simon T; Danchin N
Am J Cardiol; 2014 Dec; 114(11):1651-7. PubMed ID: 25304976
[TBL] [Abstract][Full Text] [Related]
69. Predictors of early and late target lesion revascularization after drug-eluting stent implantation.
Choi IJ; Park HJ; Seo SM; Koh YS; Lee JM; Chang K; Chung WS; Seung KB; Kim PJ
J Interv Cardiol; 2013 Apr; 26(2):137-44. PubMed ID: 23163343
[TBL] [Abstract][Full Text] [Related]
70. Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock.
Ledwoch J; Fuernau G; Desch S; Eitel I; Jung C; de Waha S; Poess J; Schneider S; Schuler G; Werdan K; Zeymer U; Thiele H
Heart; 2017 Aug; 103(15):1177-1184. PubMed ID: 28174212
[TBL] [Abstract][Full Text] [Related]
71. Impact of anaemia on long-term outcomes in patients treated with first- and second-generation drug-eluting stents; Katowice-Zabrze Registry.
Wańha W; Kawecki D; Roleder T; Pluta A; Marcinkiewicz K; Dola J; Morawiec B; Krzych Ł; Pawłowski T; Smolka G; Ochała A; Nowalany-Kozielska E; Tendera M; Wojakowski W
Kardiol Pol; 2016; 74(6):561-9. PubMed ID: 26575311
[TBL] [Abstract][Full Text] [Related]
72. Clinical outcomes following percutaneous coronary intervention before and after introduction of drug-eluting stent.
Naito R; Miyauchi K; Ogita M; Tsuboi S; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Daida H
Cardiovasc Interv Ther; 2015 Oct; 30(4):338-46. PubMed ID: 25893655
[TBL] [Abstract][Full Text] [Related]
73. Long-term clinical outcome of alternative treatment strategies for drug-eluting stents restenosis.
Liistro F; Fineschi M; Grotti S; Angioli P; Carrera A; Ducci K; Gori T; Falsini G; Pierli C; Bolognese L
EuroIntervention; 2009 Sep; 5(4):454-9. PubMed ID: 19755333
[TBL] [Abstract][Full Text] [Related]
74. Comparison of percutaneous coronary intervention for previously treated versus de novo culprit lesions in acute myocardial infarction patients: insights from the National Cardiovascular Data Registry.
Chin CT; Messenger JC; Dai D; McCoy LA; Kutcher MA; Anderson HV; Roe MT; Wang TY
Am Heart J; 2014 Mar; 167(3):393-400.e1. PubMed ID: 24576525
[TBL] [Abstract][Full Text] [Related]
75. Predictors of reocclusion after successful drug-eluting stent-supported percutaneous coronary intervention of chronic total occlusion.
Valenti R; Vergara R; Migliorini A; Parodi G; Carrabba N; Cerisano G; Dovellini EV; Antoniucci D
J Am Coll Cardiol; 2013 Feb; 61(5):545-50. PubMed ID: 23273395
[TBL] [Abstract][Full Text] [Related]
76. Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study.
Yeh RW; Chandra M; McCulloch CE; Go AS
BMC Med; 2011 Jun; 9():78. PubMed ID: 21702899
[TBL] [Abstract][Full Text] [Related]
77. Relationship between stent type and quality of life after percutaneous coronary intervention for acute myocardial infarction.
Chhatriwalla AK; Venkitachalam L; Kennedy KF; Stolker JM; Jones PG; Cohen DJ; Spertus JA
Am Heart J; 2015 Oct; 170(4):796-804.e3. PubMed ID: 26386804
[TBL] [Abstract][Full Text] [Related]
78. Factors Associated With the Use of Bare Metal Stents in Patients With ST Elevation Myocardial Infarction.
Raj L; Upadyhay R; Clavijo LC; Tun H; Mehra A; Hindoyan A; Matthews RV; Shavelle DM
Cardiovasc Revasc Med; 2020 Dec; 21(12):1489-1492. PubMed ID: 32448777
[TBL] [Abstract][Full Text] [Related]
79. Prognostic utility of the SYNTAX score in patients with single versus multivessel disease undergoing percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial).
Caixeta A; Généreux P; Palmerini T; Lansky AJ; Mehran R; Dangas GD; Xu K; Brener SJ; Stone GW
Am J Cardiol; 2014 Jan; 113(2):203-10. PubMed ID: 24176063
[TBL] [Abstract][Full Text] [Related]
80. Impact of drug-eluting stent generation on patient- and stent-related adverse events of diabetic patients treated by percutaneous coronary intervention.
D'Amico G; Fabris T; Mojoli M; Napodano M; Frigo AC; Buja P; Hoxha B; Lunardon A; Zanetti C; Isabella G; Iliceto S; Tarantini G
Minerva Cardioangiol; 2014 Feb; 62(1):9-18. PubMed ID: 24500213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
